Breast Cancer Causes
Breast Cancer Causes
There is no single cause of breast cancer. What exists is a set of factors that shift the odds, some of them fixed and some of them not — and knowing which is which is what makes a risk conversation useful rather than frightening.
Age, and lifetime exposure to oestrogen
Age is the strongest single risk factor. Incidence rises steadily after the mid-forties and continues to rise, which is why screening programmes are organised around age rather than around symptoms. Being older is not a cause in itself; it is time during which the accumulated events that turn a cell malignant become more likely.
The second organising principle is oestrogen exposure. Breast tissue responds to oestrogen, and the total number of years breast cells are exposed to it is associated with risk — which is why the age at which periods began, the age at menopause and the number of pregnancies carried to term appear repeatedly in the literature.
Inherited risk: a minority of cases, the highest stakes
Around one case in ten is associated with an inherited predisposition, and the best-known of these involve BRCA1 and BRCA2 . A woman carrying a BRCA1 mutation faces a substantially elevated lifetime risk of breast cancer and also of ovarian cancer; the estimates vary by study and by family, which is why a genetic counsellor works with the actual mutation and family history rather than with a headline figure.
-
Other genes that matter
TP53, PALB2, CHEK2, PTEN and STK11 are among the other genes associated with raised risk, each with its own pattern and its own surveillance implications. Multi-gene panel testing is now standard where testing is indicated, because testing only BRCA1 and BRCA2 will miss a proportion of families with a real inherited cause.
-
When testing is worth doing
Testing is indicated for patients with triple-negative breast cancer diagnosed young, with bilateral disease, with breast and ovarian cancer in the same person, with male breast cancer, or with a strong family history across generations. Where a mutation is found, the result changes surveillance for the patient and is testable for relatives.
-
Family history without a mutation
Most women with a family history do not carry an identifiable mutation, and their risk is still meaningfully higher than average. A first-degree relative with breast cancer roughly doubles the risk; two affected relatives raise it further; cancer in a male relative or ovarian cancer at any age in the family are additional signals. This group is managed with earlier and more frequent imaging.
-
What a normal test does not mean
A negative panel does not remove risk, because only known genes are examined. For a family with a strong pattern and no finding, surveillance is still arranged on the basis of the family history itself.
Reproductive history and hormonal treatments
These factors describe how long breast tissue has been exposed to endogenous hormones. They describe populations, not individuals — which is why they are frequently misunderstood.
| Factor | Direction of risk | Practical implication |
|---|---|---|
| Menopause after 55 | Higher | Nothing to be done about it; contributes to the case for regular screening |
| First period before 12 | Higher | Increases the value of screening from the recommended starting age |
| First birth after 30, or no pregnancy | Higher | A modest effect at population level; not a reason to alter family plans |
| Breastfeeding | Slightly lower | One of the few reproductive factors that moves risk in a favourable direction |
| Combined hormone replacement therapy | Higher with prolonged use | Discussed case by case with the prescribing doctor; short-term use for severe symptoms is a different calculation |
| Oral contraceptive use | Slightly higher while in use | The effect is small and declines after stopping |
Directions of effect follow international guideline consensus; the size of any individual effect is small relative to age and inherited risk.
What can actually be changed
This is the part of the page that matters most, because it is the only part anyone can act on. None of these factors is a guarantee, and none of them means that a person who develops breast cancer did something wrong.
-
Alcohol
Alcohol consumption is associated with higher breast cancer risk, and the association appears even at relatively low intakes, with risk rising as consumption rises. Reducing intake — rather than substituting one drink for another — is one of the clearest modifiable steps available.
-
Body weight after menopause
Higher body weight after menopause is associated with higher risk, because fat tissue is a source of oestrogen. Before menopause the relationship is less consistent. Regular physical activity is associated with lower risk independently of weight.
-
Physical activity
Moderate activity — the kind that raises the heart rate for a sustained period, several times a week — is associated with lower risk. The effect is modest, and it is one of the few interventions with no downside worth weighing.
A caution about how this information is used. These factors shift probabilities across populations. They do not explain any individual case, and a woman who develops breast cancer has not caused it. Genetic risk, age and chance account for far more than lifestyle does, and the purpose of knowing the modifiable factors is to have something to act on — not to assign responsibility.
Breast density, and why it is reported
Dense breast tissue — proportionally more glandular and fibrous tissue, less fat — is a modest independent risk factor, and it has a second consequence that matters more practically: on a mammogram, dense tissue and tumour both appear white, which reduces the test's sensitivity. Density is therefore reported alongside mammography results, and ultrasound is added for women with dense breasts. It is largely inherited and changes with age and hormonal status. It is worth knowing your own density category, because it determines whether mammography alone is adequate for you.
Benign breast disease and previous treatment
Not all raised risk comes from cancer history. Certain benign findings carry a modest increase, and previous radiotherapy to the chest carries a substantial one.
-
Benign findings that raise risk
Atypical ductal or lobular hyperplasia, and lobular carcinoma in situ, are associated with a higher risk of later invasive cancer and often prompt more frequent surveillance, and in some cases risk-reducing endocrine therapy. Ordinary fibrocystic change and simple cysts do not carry this implication.
-
Previous chest radiotherapy
Radiotherapy to the chest during childhood or early adulthood — for example as treatment for Hodgkin lymphoma — substantially raises the lifetime risk of breast cancer. Screening for these patients begins much earlier than usual and generally includes MRI alongside mammography, on a schedule set by a specialist.
Male breast cancer
Breast cancer in men is uncommon but real, and it is usually diagnosed later than in women because neither the patient nor the first clinician expects it. The presentation is typically a firm lump behind the nipple, sometimes with nipple discharge or skin change.
Risk is strongly associated with BRCA2 mutations in particular, with a family history of breast cancer, with conditions that alter the oestrogen-to-androgen balance, and with previous chest radiotherapy. Because a male breast is small, tumours reach the skin and chest wall early, and treatment usually involves mastectomy. Endocrine therapy follows the receptor status exactly as in women, and men with a hormone receptor-positive tumour are usually treated with tamoxifen.
Things that are not risk factors
Several widely repeated claims have no good evidence behind them, and clearing them up frees attention for the factors that do matter.
-
Not supported by evidence
Antiperspirants and deodorants; underwire bras; breast implants placed for cosmetic reasons; abortion; and stress as a direct cause. Studies large enough to detect a real effect have not found one for any of these.
-
Worth distinguishing carefully
Breast injury does not cause breast cancer, but it can draw attention to a lump that was already there. A lump appearing after trauma should still be imaged rather than attributed to the trauma itself.
What to do with this information
Risk factors are most useful when they turn into a specific plan. For most women that means knowing the age at which to begin screening and whether mammography alone is enough. For some it means genetic testing, or earlier imaging, or a discussion about risk-reducing options.
If a relative has been diagnosed, her receptor and genetic results are relevant to your own assessment, and it is worth asking for them. The prevention and screening page sets out what those plans look like in practice, and symptoms and early warning signs covers what to do if something has already changed.